Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu INRA

Home page

Micalis

Probiotiques, commensales et inflammation

The aim of this research group is to analyze the interactions between both probiotic and commensal bacteria (with potential beneficial properties) with the host to determine the molecular mechanisms of these positive effects for human and animal health. We are mainly focused on intestinal pathologies such as inflammatory bowel disease (IBD), inflammatory bowel syndrome (IBS) colorectal cancer (CRC) and intestinal parasitosis. We study through mechanistic and global approaches in vitro (cellular models) and in vivo (murine models and clinical trials in humans and dogs) the potential effects of probiotic and commensal bacteria in order to decipher the mechanisms governing this crosstalk. We are also working on the use of recombinant lactic acid bacteria (LAB) to deliver molecules of health interest (eg. anti-oxidants, anti-inflammatories, vaccines, etc.) and in the selection and characterization of novel probiotic strains for the development of new probiotic supplements.

Luis

Luis Bermudez-Humaran

The ultimate goal of our group is to move towards the development of a new bacteriotherapy for both humans and animals

Procominf 2017

From left to right (2017) : Rebeca Martin-Rosique; Pamela Gonzalez; Bruno Campos; Anne Aucouturier; Philippe Langella;

Pauline Ruffié; Anne Sophie Boucard;Luis Bermudez-Humaran; Isabelle Naas; Elsa Jacouton; Florian Chain; Pierre Belhumeur;

Monica Barone; Véronique Robert; Célia Chamignon

People :

Luis Bermudez-Humaran | PI

Florian Chain | Research Engineer

Philippe Langella | Head of the team but also member of this group

Anne Judith Waligora | Professor, Paris-Descartes University

Rebeca Martin-Rosique | PI

Elsa Jacouton | Post-Doc

Anne Aucouturier | Engineer associate

Edgar Torres-Maravilla | Post-Doc

Sead Chadi | Engineer associate

Sintia Almeida | Post-Doc

Véronique Robert | Engineer associate

Célia Chamignon | PhD student

Pauline Ruffié | Research Engineer

Sophie Gontier | Engineer

Sabrina Karri | M2 student

Flore Maillard | M2 student

Silvia Malavolta | M2 student

Former members of the group :

Isabelle Naas

Bruno Campos

Marion Lenoir

Pascale Kharrat

Jean-Jacques Gratadoux

Sylvia Le Guin

Aurore Thorigné

Caroline Dausset

Thibault Allain

Noura Kechaou

Laure Laval

Bouasria Benbouziane

Ana Paula Pessoa

Rodrigo Dias

Camille Aubry

Thomas Larcher

Jasmine Sridar

Chloé Raynal

Odile Rivoarilala

Diego Munoz

Pedro Ribelles

Fabien Dumetz

Laurie Watterlot

Tatiana Rochat